Kidney TransplantationImmunosuppressive AgentsGraft RejectionTacrolimusCyclosporineBK VirusMycophenolic AcidGraft SurvivalKidneyPolyomavirus InfectionsKidney DiseasesKidney Failure, ChronicQ-SortTransplantation, HomologousImmunosuppressionAntilymphocyte SerumPostoperative ComplicationsLiver TransplantationTime FactorsTissue DonorsDrug MonitoringRetrospective StudiesTransplantationCalcineurinTreatment OutcomeCreatinineHeart TransplantationFollow-Up StudiesRisk FactorsSirolimusGlomerular Filtration RateProspective StudiesBiopsyLiving DonorsSunlightDrug Therapy, CombinationTransplantsOrgan TransplantationLung TransplantationPancreas TransplantationWaiting ListsBiological MarkersIncidenceCadaverCytomegalovirus InfectionsTissue and Organ ProcurementDelayed Graft FunctionKidney Function TestsImmunocompromised HostHistocompatibility TestingIsoantibodiesTransplantation ImmunologyRenal DialysisBone Marrow TransplantationTablets, Enteric-CoatedKidney TubulesAzathioprineCyclosporinsDirected Tissue DonationCytomegalovirusGingival OvergrowthAcute Kidney InjuryRenal InsufficiencyHLA AntigensPrimary Graft DysfunctionPostoperative PeriodLymphoproliferative DisordersGanciclovirIranBronchiolitis ObliteransHeart-Lung TransplantationGingival HyperplasiaMonitoring, ImmunologicSurvival RateCohort StudiesKidney CortexAntiviral AgentsDonor SelectionLiver FailurePrednisoneRisk AssessmentComplement C4bProportional Hazards ModelsAcute DiseasePrognosisMycosesHematopoietic Stem Cell TransplantationKaplan-Meier EstimateProteinuriaSurvival AnalysisPlasmapheresisRecurrenceIMP DehydrogenaseChi-Square DistributionChronic DiseaseKidney GlomerulusCalcimimetic AgentsGingival HypertrophyKidney NeoplasmsMultivariate Analysis